CTRI/2018/05/014177尚未招募未知
Breakthrough IFIs after posaconazole prophylaxis in allogeneic BMT patients
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients undergone allogeneic bone marrow transplant and on posaconazole prophylaxis between 1st January 2015 to 31st December 2017
排除标准
- •Patients previously treated with antifungal therapy for invasive fungal infections anytime before transplant
研究者
相似试验
进行中（未招募）
1 期
Study of posaconazole prophylaxis in patients receiving hematopoietic stem cell allograft (allo-HSC) at high risk of invasive fungal infection (IFI): POSALLO study30 adult patients due to receive an allograft for a myeloid or lymphoid hematological malignancy with an HLA-matched donor from the family or from the international donor file will be included in the hematology departments of the Nantes University Hospital.CTIS2024-511507-42-00Centre Hospitalier Universitaire De Nantes30
进行中（未招募）
不适用
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPODChildren with chronic granulomatous disease (CGD).MedDRA version: 9.1Level: LLTClassification code 10008906Term: Chronic granulomatous diseaseEUCTR2008-004518-28-NLRadboud University Nijmegen Medical Centre
已完成
2 期
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD).CGDNL-OMON32626niversitair Medisch Centrum Sint Radboud20
进行中（未招募）
不适用
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPODEUCTR2008-004518-28-GBRadboud University Nijmegen Medical Centre20
已完成
不适用
Intravenous Fluconazole prophylaxis in preterm neonatesCandidial sepsis.Neonatal candidiasisIRCT2014051411499N1Research Vice-Canceller of Tabriz University of Medical Sciences100